Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 1997

View Archived Issues

Immune Response's TCR vaccine evaluated in MS patients

Parke-Davis initiates QUASAR trial of quinapril

Dovetail issued patent for Betathine

Pacific Pharmaceuticals and Steri-Oss sign distribution agreement

Familial Mediterranean fever gene discovered

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

BMS reports new cephalosporins active against MRSA

Tasmar approved in EU for Parkinson's disease

Gensia's injectable diltiazem receives ANDA approval

Roche withdraws NDA for orlistat

FDA approves Hi-Tech's generic promethazine/codeine syrup

Marketing agreement reached for Abelcet in France and Italy

Eurand and Global enter pancrelipase agreement

Canadian marketing clearance granted for Emdogain

Morphine derivatives discovered by Nycomed

FDA approves nonsurgical treatment for BPH

ImmunoGen's apoptosis research receives patent protection

Alza will acquire Therapeutic Discovery Corporation

Val-HeFT will evaluate valsartan in CHF

New Parkinson's disease treatment option now available in Canada

New indication approved for Asacol

First regulatory submission filed for Macritonin

CURVES study results point in favor of atorvastatin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...